These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 22269678)

  • 81. Keratoprosthesis: current techniques.
    Aquavella JV; Qian Y; McCormick GJ; Palakuru JR
    Cornea; 2006 Jul; 25(6):656-62. PubMed ID: 17077656
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Boston Type 1 Keratoprosthesis versus Repeat Donor Keratoplasty for Corneal Graft Failure: A Systematic Review and Meta-analysis.
    Ahmad S; Mathews PM; Lindsley K; Alkharashi M; Hwang FS; Ng SM; Aldave AJ; Akpek EK
    Ophthalmology; 2016 Jan; 123(1):165-77. PubMed ID: 26545318
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A Foldable Nonpenetrating Keratoprosthesis: Medium to Long-Term Clinical Results in Patients with Corneal Blindness due to Noninflammatory Anterior Cornea Disease.
    Vargas JM; Shiuey E
    Middle East Afr J Ophthalmol; 2020; 27(3):150-155. PubMed ID: 33488010
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mid-term prognosis of type I Boston keratoprosthesis reimplantation.
    Bouhout S; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jan; 106(1):37-41. PubMed ID: 33055084
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Management of corneal melt in patients with Boston Keratoprosthesis Type 1: Repair versus repeat.
    Daoud R; Sabeti S; Harissi-Dagher M
    Ocul Surf; 2020 Oct; 18(4):713-717. PubMed ID: 32777438
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Microbial Keratitis and Endophthalmitis After the Boston Type 1 Keratoprosthesis.
    Wagoner MD; Welder JD; Goins KM; Greiner MA
    Cornea; 2016 Apr; 35(4):486-93. PubMed ID: 26764885
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
    Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
    Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
    Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
    Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
    Kaufman AR; Cruzat A; Colby KA
    Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Boston type 1 keratoprosthesis outcomes in ocular burns.
    Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
    Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Importance of nutrition to corneal grafts when used as a carrier of the Boston Keratoprosthesis.
    Harissi-Dagher M; Khan BF; Schaumberg DA; Dohlman CH
    Cornea; 2007 Jun; 26(5):564-8. PubMed ID: 17525653
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.
    Karas FI; Arteaga A; Barrionuevo P; Cao D; McAnany JJ; Shorter E; Cortina MS
    Cornea; 2019 Jan; 38(1):50-53. PubMed ID: 30157051
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term outcomes of MICOF keratoprosthesis in the end stage of autoimmune dry eyes: an experience in China.
    Huang Y; Dong Y; Wang L; Du G; Yu J; Song J; Chiang HH
    Br J Ophthalmol; 2012 Jan; 96(1):28-33. PubMed ID: 21454379
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Russian Keratoprosthesis in Stevens-Johnson Syndrome.
    Ma X; Xiang R; Meng X; Qin L; Wu Y; Tain L; Jiang Y; Huang Y; Wang L
    Cornea; 2017 Mar; 36(3):304-309. PubMed ID: 27941382
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Anterior segment optical coherence tomography in the long-term follow-up and detection of glaucoma in Boston type I keratoprosthesis.
    Qian CX; Hassanaly S; Harissi-Dagher M
    Ophthalmology; 2015 Feb; 122(2):317-25. PubMed ID: 25264027
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
    Aoun T; Harissi-Dagher M
    J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Mid- and Longterm Experiences with the Boston-Keratoprosthesis. The Cologne and Salzburg Perspective].
    Schaub F; Bachmann BO; Seyeddain O; Moussa S; Reitsamer HA; Cursiefen C
    Klin Monbl Augenheilkd; 2017 Jun; 234(6):770-775. PubMed ID: 28586930
    [No Abstract]   [Full Text] [Related]  

  • 99. Ten-Year Outcome of Boston Type I Keratoprosthesis Surgery at a Tertiary Care Center.
    Tsou BC; Koseoglu ND; Akpek EK; Liu TYA
    Cornea; 2024 Aug; 43(8):982-988. PubMed ID: 38305331
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [The Boston keratoprosthesis].
    Wang L; Huang Y; James C; Dohlman CH
    Zhonghua Yan Ke Za Zhi; 2014 Apr; 50(4):307-12. PubMed ID: 24931158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.